Regulation of Claspin by the p38 stress-activated protein kinase protects cells from DNA damage
| dc.contributor.author | Ulsamer, Arnau | |
| dc.contributor.author | Martínez Limón, Adrián | |
| dc.contributor.author | Bader, S | |
| dc.contributor.author | Rodríguez Acebes, Sara | |
| dc.contributor.author | Freire, Raimundo | |
| dc.contributor.author | Méndez, Juan | |
| dc.contributor.author | Nadal Clanchet, Eulàlia de | |
| dc.contributor.author | Posas, Francesc | |
| dc.date.accessioned | 2025-04-25T09:23:57Z | |
| dc.date.available | 2025-04-25T09:23:57Z | |
| dc.date.issued | 2022-09-20 | |
| dc.date.updated | 2025-04-23T07:18:57Z | |
| dc.description.abstract | Stress-activated protein kinases (SAPKs) enhance survival in response to environmental changes. In yeast, the Hog1 SAPK and Mrc1, a protein required for DNA replication, define a safeguard mechanism that allows eukaryotic cells to prevent genomic instability upon stress during S-phase. Here we show that, in mammals, the p38 SAPK and Claspin-the functional homolog of Mrc1-protect cells from DNA damage upon osmostress during S-phase. We demonstrate that p38 phosphorylates Claspin and either the mutation of the p38-phosphorylation sites in Claspin or p38 inhibition suppresses the protective role of Claspin on DNA damage. In addition, wild-type Claspin but not the p38-unphosphorylatable mutant has a protective effect on cell survival in response to cisplatin treatment. These findings reveal a role of Claspin in response to chemotherapeutic drugs. Thus, this pathway protects S-phase integrity from different insults and it is conserved from yeast to mammals. | |
| dc.format.extent | 17 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idimarina | 6567540 | |
| dc.identifier.issn | 2211-1247 | |
| dc.identifier.pmid | 36130506 | |
| dc.identifier.uri | https://hdl.handle.net/2445/220608 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1016/j.celrep.2022.111375 | |
| dc.relation.ispartof | Cell Reports, 2022, vol. 40, num. 12 | |
| dc.relation.uri | https://doi.org/10.1016/j.celrep.2022.111375 | |
| dc.rights | cc-by-nc-nd (c) Ulsamer, Arnau et al., 2022 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
| dc.source | Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona)) | |
| dc.subject.classification | ADN | |
| dc.subject.classification | Estrès (Fisiologia) | |
| dc.subject.classification | Cicle cel·lular | |
| dc.subject.classification | Cisplatí | |
| dc.subject.other | DNA | |
| dc.subject.other | Stress (Physiology) | |
| dc.subject.other | Cell cycle | |
| dc.subject.other | Cisplatin | |
| dc.title | Regulation of Claspin by the p38 stress-activated protein kinase protects cells from DNA damage | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1
Carregant...
- Nom:
- Cell Reports_Ulsamer_2022.pdf
- Mida:
- 2.67 MB
- Format:
- Adobe Portable Document Format